<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - 04/28/2025</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Progress note - 04/28/2025</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">ARCADIA RAMIREZ</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">January 12, 1942 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Female</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>White</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Hispanic or Latino</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>102 N CANAL AVE<br/>MISSION, TX 78572-5023, US<br/><br/>Work Phone:  956-789-3722<br/>Primary Home Phone:  956-789-3722<br/>Mobile Phone:  956-789-3722<br/>Email:  ramirezr.2.519@gmail.com<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">182359 2.16.840.1.113883.4.391.327187<br/>182359 2.16.840.1.113883.4.391.327187.1<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">c3b5d0a3-4939-4cf2-9f42-c936ceb321ba 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">May 14, 2025, 17:51:26 -0400 </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Hobert Smith</td></tr><tr><td class="td_header_role_value internal_format">501 N WARE RD<br/>MCALLEN, TX 78501-8055, US<br/><br/>Tel:  956-668-0044<br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Arely Martinez</td></tr><tr><td class="td_header_role_value internal_format">501 N WARE RD<br/>MCALLEN, TX 78501-8055, US<br/><br/>Tel:  956-668-0044<br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Orlando Valdes Rodriguez</td></tr><tr><td class="td_header_role_value internal_format">501 N WARE RD<br/>MCALLEN, TX 78501-8055, US<br/><br/>Tel:  956-668-0044<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">450d4d2d-4392-3e4a-b457-9596f3dcb22d 2.16.840.1.113883.4.391.327187</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">ambulatory</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From April 28, 2025, 16:00:00   to April 28, 2025, 16:20:00  </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">id:  2.16.840.1.113883.4.391.327187</td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">Orlando Valdes Rodriguez</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">501 N WARE RD<br/>MCALLEN, TX 78501-8055, US<br/><br/>Tel:  956-668-0044<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Emergency contact</span></td><td class="td_header_role_value">ROXANNA RAMIREZ<br/><br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">102 N CANAL AVE<br/>MISSION, TX 78572-5023, US<br/><br/>Tel:  956-789-3722<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">ARCADIA RAMIREZ<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  956-789-3722<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">Orlando Valdes Rodriguez signed at April 28, 2025 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">501 N WARE RD<br/>MCALLEN, TX 78501-8055, US<br/><br/>Tel:  956-668-0044<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">MyCare Medical Group</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">1785 NORTHPOINTE PKWY<br/>STE 300<br/>LUTZ, FL 33558-5742, US<br/><br/>Tel:  813-536-7277<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Problems</a></li><li><a href="#id6">Vital Signs</a></li><li><a href="#id7">Encounters</a></li><li><a href="#id8">Assessments</a></li><li><a href="#id9">Plan Of Treatment</a></li><li><a href="#id10">History and Physical Notes</a></li><li><a href="#id11">Progress Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1"/><td>Cortisone</td><td ID="reaction1">Unknown</td><td>Drug Allergy</td><td>02/15/2023</td><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>Follow up: HTN, mixed hyperlipidemia, and DM2</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Donepezil HCl 5 MG</td><td ID="instruction1">1 tablet at bedtime Orally Once a day; Duration: 100 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Clopidogrel Bisulfate 75 MG</td><td ID="instruction2">1 tablet Orally Once a day; Duration: 90 days</td><td/><td>04/28/2025</td><td/><td>Active</td></tr><tr><td ID="medication3">Aspirin 81 MG</td><td ID="instruction3">1 tablet Orally Once a day; Duration: 90 days</td><td/><td>04/28/2025</td><td/><td>Active</td></tr><tr><td ID="medication4">traZODone HCl 50 MG</td><td ID="instruction4">1 tablet at bedtime Orally Once a day; Duration: 90 days</td><td/><td>04/28/2025</td><td/><td>Active</td></tr><tr><td ID="medication5">Atorvastatin Calcium 40 MG</td><td ID="instruction5">1 tablet Orally Once a day; Duration: 100 days</td><td/><td>04/28/2025</td><td/><td>Active</td></tr><tr><td ID="medication6">Alpha Lipoic Acid 300 mg</td><td ID="instruction6">1 capsule Orally Once a day; Duration: 90 days</td><td ID="medication6notes">*Pick strength-form from Medispan for eRX*</td><td>04/28/2025</td><td/><td>Active</td></tr><tr><td ID="medication7">Vitamin D3 25 MCG (1000 UT)</td><td ID="instruction7">1 tablet Orally Once a day</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication8">Fluconazole 150 MG</td><td ID="instruction8">Take 1 tablet Orally first day then take the other tablet 72 hours apart; Duration: 2 days</td><td/><td>04/28/2025</td><td/><td>Active</td></tr><tr><td ID="medication9">Lisinopril 10 MG</td><td ID="instruction9">1 tablet Orally Once a day; Duration: 100 days</td><td/><td>04/28/2025</td><td/><td>Active</td></tr><tr><td ID="medication10">Farxiga 10 MG</td><td ID="instruction10">1 tablet Orally Once a day; Duration: 100 days</td><td/><td>04/28/2025</td><td/><td>Active</td></tr><tr><td ID="medication11">Isosorbide Mononitrate ER 30 MG</td><td ID="instruction11">1 tablet in the morning Orally Once a day</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Never Smoker</td><td>NA - NA</td></tr></tbody></table><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Female</td></tr></tbody></table><span class="content_span">Social History</span><table ID="socialhistorynotes" width="100%" border="1"><tbody><tr><td colspan="4"/></tr><tr><th colspan="4">Drugs/Alcohol:</th></tr><tr><th>Social Info</th><th>Question</th><th>Answer</th><th>Notes</th></tr><tr><td rowspan="3">Alcohol Screen (Audit-C)</td><td>Did you have a drink containing alcohol in the past year?</td><td>No</td><td/></tr><tr><td>Points</td><td>0</td><td/></tr><tr><td>Interpretation</td><td>Negative</td><td/></tr><tr><td>Caffeine</td><td>Intake:</td><td>none</td><td/></tr></tbody><tbody><tr><td colspan="4"/></tr><tr><th colspan="4">Tobacco Use:</th></tr><tr><th>Social Info</th><th>Question</th><th>Answer</th><th>Notes</th></tr><tr><td>Tobacco Use/Smoking</td><td>Tobacco use:</td><td>nonsmoker</td><td/></tr></tbody><tbody><tr><td colspan="4"/></tr><tr><th colspan="4">Additional Details</th></tr><tr><th>Category</th><th>Social Info</th><th>Options</th><th>Details</th></tr><tr><td>Drugs/Alcohol:</td><td>Do you drink alcohol?</td><td/><td>No</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>52448006</td><td ID="Problem1">Severe dementia without behavioral disturbance, psychotic disturbance, mood disturbance, or anxiety, unspecified dementia type (F03.C0)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Height</th><td>60.00 in</td><td>04/28/2025</td></tr><tr><th ID="vital2">Weight</th><td>170 lbs</td><td>04/28/2025</td></tr><tr><th ID="vital3">Weight-kg</th><td>77.11 kg</td><td>04/28/2025</td></tr><tr><th ID="vital4">BMI</th><td>33.2 kg/m2</td><td>04/28/2025</td></tr><tr><th ID="vital5">Blood pressure systolic</th><td>130 mm Hg</td><td>04/28/2025</td></tr><tr><th ID="vital6">Blood pressure diastolic</th><td>85 mm Hg</td><td>04/28/2025</td></tr><tr><th ID="vital7">Heart Rate</th><td>78 /min</td><td>04/28/2025</td></tr><tr><th ID="vital8">Temperature</th><td>98.3 degrees Fahrenheit</td><td>04/28/2025</td></tr><tr><th ID="vital9">Height-cm</th><td>152.4 cm</td><td>04/28/2025</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM McAllen</td><td>501 N WARE RD MCALLEN, TX 78501-8055</td><td>04/28/2025</td><td>Orlando Valdes Rodriguez</td><td>Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin E11.69 ; Mixed hyperlipidemia E78.2 ; Type 2 diabetes mellitus with diabetic chronic kidney disease E11.22 ; Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene, without long-term current use of insulin E11.51 ; Hyp hrt &amp; chr kdny dis w hrt fail and stg 1-4/unsp chr kdny I13.0 ; Chronic kidney disease, stage 3a N18.31 ; Immunodeficiency due to conditions classified elsewhere D84.81 ; Major depressive disorder, recurrent, mild F33.0 ; Insomnia, unspecified G47.00 ; NSTEMI (non-ST elevated myocardial infarction) I21.4 ; Severe dementia without behavioral disturbance, psychotic disturbance, mood disturbance, or anxiety, unspecified dementia type F03.C0 ; Sinus bradycardia R00.1 ; Atherosclerosis of native coronary artery of native heart without angina pectoris I25.10 ; BMI 35.0-35.9,adult Z68.35 ; Vaginal candidiasis B37.31 and Asymptomatic bacteriuria R82.71</td></tr></tbody></table></div><h3><a name="id8" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th><th>Section Notes</th></tr></thead><tbody><tr><td ID="ref1">04/28/2025</td><td>Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin (ICD-10 - E11.69)</td><td/><td><p>This is associated with hyperlipidemia. DM</p><p>well controlled.</p><p>Most recent HbA1c 6.2% on 4-8-2025</p><p>HbA1c goal &lt;8% without hypoglycemic events., PT advised pt to</p><p>continue to monitor fbs at home. advised pt to be compliant on all meds-pt VGA</p><p>PT educated on dietary restrictions including avoiding fat and carbohydrate</p><p>rich foods. Pt advised to eat a balanced diet, at regular times and not skip</p><p>meals. PT was also educated on portion control and the importance of avoidance</p><p>of simple sugars and sodas. lifestyle changes are also necessary to prevent</p><p>complications and control condition, she was encouraged to increase activity as</p><p>tolerated and lose weight. </p><p>Follow up with PCP as scheduled</p></td><td/><td/></tr><tr><td ID="ref2">04/28/2025</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td><p>Stable. </p><p>This is associated with T2 DM. </p><p>Patient advised to continue with medications as</p><p>prescribed.</p><p>Continue</p><p>with a low glycemic diet. Discussed the importance of taking a statin. Goal</p><p>maintain LDL less than 70, HDL great than 40, triglycerides less than 150 and</p><p>A1c goal &lt;8%., Recommend a "heart-healthy diet" rich in</p><p>vegetables, fruits, fiber-rich whole grains, lean meats, and poultry; fish at</p><p>least twice a week; fat-free or 1% dairy products; low in saturated and trans</p><p>fats, cholesterol, sodium, and added sugars., The patient also was advised to</p><p>exercise regularly and lose about 10 pounds., Follow up with PCP. </p></td><td/><td/></tr><tr><td ID="ref3">04/28/2025</td><td>Type 2 diabetes mellitus with diabetic chronic kidney disease (ICD-10 - E11.22)</td><td/><td><p>Stable., Secondary to diabetic nephropathy</p><p>Patient needs to take medications as</p><p>directed by MD. Stressed control of blood sugars and blood pressure. Monitor</p><p>renal function q 3-6 months. Avoid nephrotoxins, NSAIDs and need to hydrate</p><p>well. Nephrology consults prn., Patient is to control blood sugars and blood</p><p>pressure</p></td><td/><td/></tr><tr><td ID="ref4">04/28/2025</td><td>Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene, without long-term current use of insulin (ICD-10 - E11.51)</td><td/><td><p>Patient will continue strict glucose, blood pressure, and</p><p>lipid management. Increase daily physical activity as tolerated. Continue</p><p>statin. Monitor feet/legs for lesions and loss of circulation. Avoid walking</p><p>barefoot. Report any abnormal findings to PCP. </p></td><td/><td/></tr><tr><td ID="ref5">04/28/2025</td><td>Hyp hrt &amp; chr kdny dis w hrt fail and stg 1-4/unsp chr kdny (ICD-10 - I13.0)</td><td/><td><p>BP well controlled.,  BP: 130/85 mm Hg</p><p>This is ckd secondary to hypertensive nephropathy</p><p>Pt instructed to needs to avoid NSDAs and nephrotoxic drugs., to continues with</p><p>ACE inhibitor and farxiga to reduce the risk of sustained gfr decline at risk</p><p>of progression., rigorous blood pressure control should be done as early as</p><p>possible after identifying the presence of progressive ckd. Blood pressure goal</p><p>&lt; 130/80 mmhg., protective therapy has the greatest impact if it is</p><p>initiated before the plasma creatinine concentration exceeds 1.2 mg/dl or when</p><p>the egfr is &lt;60. - will keep monitoring gfr, ck </p><p>diet: decrease the daily intake of sodium, phosphorus,</p><p>calcium and potassium - avoid dehydration, contrast material.,  Pt will report new or worsening symptoms. ,</p><p>Nephrologist referral as needed.</p></td><td/><td/></tr><tr><td ID="ref6">04/28/2025</td><td>Chronic kidney disease, stage 3a (ICD-10 - N18.31)</td><td/><td><p>CKD, Stable.</p><p>Secondary to diabetic nephropathy and hypertensive nephropathy</p><p>Pt instructed to needs to avoid NSDAs and nephrotoxic drugs., to continues with</p><p>ACE inhibitor and farxiga to reduce the risk of sustained gfr decline at risk</p><p>of progression</p><p>Reinforced importance of control of risk factors, htn DM, HLD., Continue with medication</p><p>as indicated for all chronic conditions. Patient advised on the importance of</p><p>dietary modifications including a DASH, 1800 cal-ADA and low fat/cholesterol</p><p>diet. Increase water intake. Advised to stay hydrated. </p><p>Follow up with PCP.</p></td><td>Continue surveillance with kidney specialist Dr Franklin Ponce Herrera. LOV 3-31-2025</td><td/></tr><tr><td ID="ref7">04/28/2025</td><td>Immunodeficiency due to conditions classified elsewhere (ICD-10 - D84.81)</td><td/><td><p>Patient is immunosuppressed due to DM. Discussed with patient that</p><p>chronic elevated blood sugars increased risk for infections due to</p><p>immunosuppression. Will revise medication list and observe for potential changes.</p><p>Stressed the importance of diet and exercise. Patient understands risk. Patient advised to seek medical care if she develops</p><p>any clinical signs and symptoms suggestive of infection.</p></td><td/><td/></tr><tr><td ID="ref8">04/28/2025</td><td>Major depressive disorder, recurrent, mild (ICD-10 - F33.0)</td><td/><td><p>Currently patient</p><p>is asymptomatic.; symptoms are stable., Plan to continue current management</p><p>and to re-evaluate patient at follow up., Patient denies suicidal or</p><p>homicidal ideation.  pt to notify provider of any behavioral changes</p><p>or suicidal thoughts. Patient was advised to call or come in if symptoms</p><p>develop., pt to participate in daily activities and socializing when he starts</p><p>to feel down. RTC as scheduled. PHQ yearly, and prn., Patient verbalized</p><p>understanding. </p><p> </p></td><td/><td/></tr><tr><td ID="ref9">04/28/2025</td><td>Insomnia, unspecified (ICD-10 - G47.00)</td><td/><td>Review proper sleeping hygiene. Avoid exercising and stimulating activities in the evening. Encourage reading and soothing noises. Thoroughly discussed sleep hygiene and non-stimulating activities before bed, reduce caffeine. He was recommended to avoid napping during day. Start exercise at least 30 minutes daily. May use chamomile tea before bed to help induce sleep. Will continue to follow up with patient.</td><td/><td/></tr><tr><td ID="ref10">04/28/2025</td><td>NSTEMI (non-ST elevated myocardial infarction) (ICD-10 - I21.4)</td><td/><td>As per hospital discharge summary. Advised to continue with current medications. Refill provided. I will refer patient Cardiologist for evaluation and treatment. </td><td/><td/></tr><tr><td ID="ref11">04/28/2025</td><td>Severe dementia without behavioral disturbance, psychotic disturbance, mood disturbance, or anxiety, unspecified dementia type (ICD-10 - F03.C0)</td><td/><td><p>stable. monitor closely.</p><p>med refilled </p><p>Encouraged memory exercises daily. Maintain routine schedule whenever possible with ADL's and meal time.</p></td><td/><td/></tr><tr><td ID="ref12">04/28/2025</td><td>Sinus bradycardia (ICD-10 - R00.1)</td><td/><td><p>As per hospital discharge summary</p><p>Refer to Cardiologist for evaluation and treatment. </p></td><td/><td/></tr><tr><td ID="ref13">04/28/2025</td><td>Atherosclerosis of native coronary artery of native heart without angina pectoris (ICD-10 - I25.10)</td><td/><td><p>Pt has stable BP with no cp or sob with good functional status and adequate BP control.</p><p>Recommend exercise program as tolerated and high fiber, low sodium, low saturated fat, low refined sugar diet. Continue with current medications as prescribed. Follow up with PCP and cardiologist as scheduled and as needed. If chest pain should occur, call, or go to the hospital Emergency Department via EMS 911. Targets for blood pressure, lipids, glucose reviewed.</p></td><td/><td/></tr><tr><td ID="ref14">04/28/2025</td><td>BMI 35.0-35.9,adult (ICD-10 - Z68.35)</td><td/><td>Encouraged and stressed importance of diet and physical activity to improve BMI and overall health.  Discussed obtaining goal BMI through diet and exercise program.</td><td/><td/></tr><tr><td ID="ref15">04/28/2025</td><td>Vaginal candidiasis (ICD-10 - B37.31)</td><td/><td><p>Trial fluconazol x 2 doses </p><p>Pt denies Hx of DM, immunodeficiency, chronic steroid use, excessive doucing, or recent Abx use. Pt advised to keep vagina dry, use 100% cotton underwear, avoid tight-fitting clothing, and avoid use of feminine deodorants/bubble baths.</p></td><td/><td/></tr><tr><td ID="ref16">04/28/2025</td><td>Asymptomatic bacteriuria (ICD-10 - R82.71)</td><td/><td><p>She has not s/s UTI currently</p><p>Suspected contamination</p><p>Will repeact UA</p></td><td/><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Donepezil HCl 5 MG</td><td>1 tablet at bedtime Orally Once a day; Duration: 100 days</td><td/><td/><td/></tr><tr><td ID="potMeds2">Clopidogrel Bisulfate 75 MG</td><td>1 tablet Orally Once a day; Duration: 90 days</td><td>04/28/2025</td><td/><td/></tr><tr><td ID="potMeds3">Aspirin 81 MG</td><td>1 tablet Orally Once a day; Duration: 90 days</td><td>04/28/2025</td><td/><td/></tr><tr><td ID="potMeds4">traZODone HCl 50 MG</td><td>1 tablet at bedtime Orally Once a day; Duration: 90 days</td><td>04/28/2025</td><td/><td/></tr><tr><td ID="potMeds5">Atorvastatin Calcium 40 MG</td><td>1 tablet Orally Once a day; Duration: 100 days</td><td>04/28/2025</td><td/><td/></tr><tr><td ID="potMeds6">Alpha Lipoic Acid 300 mg</td><td>1 capsule Orally Once a day; Duration: 90 days</td><td>04/28/2025</td><td/><td>*Pick strength-form from Medispan for eRX*</td></tr><tr><td ID="potMeds7">Fluconazole 150 MG</td><td>Take 1 tablet Orally first day then take the other tablet 72 hours apart; Duration: 2 days</td><td>04/28/2025</td><td/><td/></tr><tr><td ID="potMeds8">Lisinopril 10 MG</td><td>1 tablet Orally Once a day; Duration: 100 days</td><td>04/28/2025</td><td/><td/></tr><tr><td ID="potMeds9">Farxiga 10 MG</td><td>1 tablet Orally Once a day; Duration: 100 days</td><td>04/28/2025</td><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin</td><td><p>This is associated with hyperlipidemia. DM</p><p>well controlled.</p><p>Most recent HbA1c 6.2% on 4-8-2025</p><p>HbA1c goal &lt;8% without hypoglycemic events., PT advised pt to</p><p>continue to monitor fbs at home. advised pt to be compliant on all meds-pt VGA</p><p>PT educated on dietary restrictions including avoiding fat and carbohydrate</p><p>rich foods. Pt advised to eat a balanced diet, at regular times and not skip</p><p>meals. PT was also educated on portion control and the importance of avoidance</p><p>of simple sugars and sodas. lifestyle changes are also necessary to prevent</p><p>complications and control condition, she was encouraged to increase activity as</p><p>tolerated and lose weight. </p><p>Follow up with PCP as scheduled</p></td></tr><tr><td ID="instructionpot2">Mixed hyperlipidemia</td><td><p>Stable. </p><p>This is associated with T2 DM. </p><p>Patient advised to continue with medications as</p><p>prescribed.</p><p>Continue</p><p>with a low glycemic diet. Discussed the importance of taking a statin. Goal</p><p>maintain LDL less than 70, HDL great than 40, triglycerides less than 150 and</p><p>A1c goal &lt;8%., Recommend a "heart-healthy diet" rich in</p><p>vegetables, fruits, fiber-rich whole grains, lean meats, and poultry; fish at</p><p>least twice a week; fat-free or 1% dairy products; low in saturated and trans</p><p>fats, cholesterol, sodium, and added sugars., The patient also was advised to</p><p>exercise regularly and lose about 10 pounds., Follow up with PCP. </p></td></tr><tr><td ID="instructionpot3">Type 2 diabetes mellitus with diabetic chronic kidney disease</td><td><p>Stable., Secondary to diabetic nephropathy</p><p>Patient needs to take medications as</p><p>directed by MD. Stressed control of blood sugars and blood pressure. Monitor</p><p>renal function q 3-6 months. Avoid nephrotoxins, NSAIDs and need to hydrate</p><p>well. Nephrology consults prn., Patient is to control blood sugars and blood</p><p>pressure</p></td></tr><tr><td ID="instructionpot4">Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene, without long-term current use of insulin</td><td><p>Patient will continue strict glucose, blood pressure, and</p><p>lipid management. Increase daily physical activity as tolerated. Continue</p><p>statin. Monitor feet/legs for lesions and loss of circulation. Avoid walking</p><p>barefoot. Report any abnormal findings to PCP. </p></td></tr><tr><td ID="instructionpot5">Hyp hrt &amp; chr kdny dis w hrt fail and stg 1-4/unsp chr kdny</td><td><p>BP well controlled.,  BP: 130/85 mm Hg</p><p>This is ckd secondary to hypertensive nephropathy</p><p>Pt instructed to needs to avoid NSDAs and nephrotoxic drugs., to continues with</p><p>ACE inhibitor and farxiga to reduce the risk of sustained gfr decline at risk</p><p>of progression., rigorous blood pressure control should be done as early as</p><p>possible after identifying the presence of progressive ckd. Blood pressure goal</p><p>&lt; 130/80 mmhg., protective therapy has the greatest impact if it is</p><p>initiated before the plasma creatinine concentration exceeds 1.2 mg/dl or when</p><p>the egfr is &lt;60. - will keep monitoring gfr, ck </p><p>diet: decrease the daily intake of sodium, phosphorus,</p><p>calcium and potassium - avoid dehydration, contrast material.,  Pt will report new or worsening symptoms. ,</p><p>Nephrologist referral as needed.</p></td></tr><tr><td ID="instructionpot6">Chronic kidney disease, stage 3a</td><td><p>CKD, Stable.</p><p>Secondary to diabetic nephropathy and hypertensive nephropathy</p><p>Pt instructed to needs to avoid NSDAs and nephrotoxic drugs., to continues with</p><p>ACE inhibitor and farxiga to reduce the risk of sustained gfr decline at risk</p><p>of progression</p><p>Reinforced importance of control of risk factors, htn DM, HLD., Continue with medication</p><p>as indicated for all chronic conditions. Patient advised on the importance of</p><p>dietary modifications including a DASH, 1800 cal-ADA and low fat/cholesterol</p><p>diet. Increase water intake. Advised to stay hydrated. </p><p>Follow up with PCP.</p></td></tr><tr><td ID="instructionpot7">Immunodeficiency due to conditions classified elsewhere</td><td><p>Patient is immunosuppressed due to DM. Discussed with patient that</p><p>chronic elevated blood sugars increased risk for infections due to</p><p>immunosuppression. Will revise medication list and observe for potential changes.</p><p>Stressed the importance of diet and exercise. Patient understands risk. Patient advised to seek medical care if she develops</p><p>any clinical signs and symptoms suggestive of infection.</p></td></tr><tr><td ID="instructionpot8">Major depressive disorder, recurrent, mild</td><td><p>Currently patient</p><p>is asymptomatic.; symptoms are stable., Plan to continue current management</p><p>and to re-evaluate patient at follow up., Patient denies suicidal or</p><p>homicidal ideation.  pt to notify provider of any behavioral changes</p><p>or suicidal thoughts. Patient was advised to call or come in if symptoms</p><p>develop., pt to participate in daily activities and socializing when he starts</p><p>to feel down. RTC as scheduled. PHQ yearly, and prn., Patient verbalized</p><p>understanding. </p><p> </p></td></tr><tr><td ID="instructionpot9">Insomnia, unspecified</td><td>Review proper sleeping hygiene. Avoid exercising and stimulating activities in the evening. Encourage reading and soothing noises. Thoroughly discussed sleep hygiene and non-stimulating activities before bed, reduce caffeine. He was recommended to avoid napping during day. Start exercise at least 30 minutes daily. May use chamomile tea before bed to help induce sleep. Will continue to follow up with patient.</td></tr><tr><td ID="instructionpot10">NSTEMI (non-ST elevated myocardial infarction)</td><td>As per hospital discharge summary. Advised to continue with current medications. Refill provided. I will refer patient Cardiologist for evaluation and treatment. </td></tr><tr><td ID="instructionpot11">Severe dementia without behavioral disturbance, psychotic disturbance, mood disturbance, or anxiety, unspecified dementia type</td><td><p>stable. monitor closely.</p><p>med refilled </p><p>Encouraged memory exercises daily. Maintain routine schedule whenever possible with ADL's and meal time.</p></td></tr><tr><td ID="instructionpot12">Sinus bradycardia</td><td><p>As per hospital discharge summary</p><p>Refer to Cardiologist for evaluation and treatment. </p></td></tr><tr><td ID="instructionpot13">Atherosclerosis of native coronary artery of native heart without angina pectoris</td><td><p>Pt has stable BP with no cp or sob with good functional status and adequate BP control.</p><p>Recommend exercise program as tolerated and high fiber, low sodium, low saturated fat, low refined sugar diet. Continue with current medications as prescribed. Follow up with PCP and cardiologist as scheduled and as needed. If chest pain should occur, call, or go to the hospital Emergency Department via EMS 911. Targets for blood pressure, lipids, glucose reviewed.</p></td></tr><tr><td ID="instructionpot14">BMI 35.0-35.9,adult</td><td>Encouraged and stressed importance of diet and physical activity to improve BMI and overall health.  Discussed obtaining goal BMI through diet and exercise program.</td></tr><tr><td ID="instructionpot15">Vaginal candidiasis</td><td><p>Trial fluconazol x 2 doses </p><p>Pt denies Hx of DM, immunodeficiency, chronic steroid use, excessive doucing, or recent Abx use. Pt advised to keep vagina dry, use 100% cotton underwear, avoid tight-fitting clothing, and avoid use of feminine deodorants/bubble baths.</p></td></tr><tr><td ID="instructionpot16">Asymptomatic bacteriuria</td><td><p>She has not s/s UTI currently</p><p>Suspected contamination</p><p>Will repeact UA</p></td></tr></tbody></table><span class="content_span">Future Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="futureTest1">1505 URINALYSIS WITH MICROSCOPIC</td><td>04/28/2025</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 3 Months, Reason: Follow-up of chronic conditions</td></tr></tbody></table></div><h3><a name="id10" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th><th>Category Notes</th></tr></thead><tbody><tr><td rowspan="8">General Examination</td><td>General appearance:</td><td colspan="2">well-appearing, no acute distress , morbid obese , chaperone present in room, (daughter)</td><td rowspan="8"/></tr><tr><td>Neck / thyroid:</td><td colspan="2">no JVD, no lymphadenopathy, no thyromegaly, no carotid bruit</td></tr><tr><td>Heart:</td><td colspan="2">regular rhythm, S1S2 normal, no S3 S4, no murmur, gallop or rub</td></tr><tr><td>Chest:</td><td colspan="2">symmetric without any chest wall tenderness</td></tr><tr><td>Lungs:</td><td colspan="2">clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes</td></tr><tr><td>Abdomen:</td><td colspan="2">soft, non tender, not distended, BS +, no organomegaly</td></tr><tr><td>Neurologic:</td><td colspan="2">conscious, AAO x 3, no new focal deficits</td></tr><tr><td>Extremities</td><td colspan="2">no edema</td></tr></tbody></table><br/></li></ul></div><h3><a name="id11" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>RAMIREZ, ARCADIA <span class="bold">DOB:</span> 01/12/1942 (83 yo F) <span class="bold">Acc No.</span> 182359 <span class="bold">DOS:</span> 04/28/2025</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold"/></td></tr><tr><td align="left"><span class="bold">Patient: </span>RAMIREZ, ARCADIA<br/><span class="bold">Account Number: </span>182359</td><td align="right"><span class="bold">Provider: </span>Orlando Valdes Rodriguez, NP</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>01/12/1942<span class="bold">   Age: </span>83 Y<span class="bold">   Sex: </span>Female</td><td align="right"><span class="bold">Date: </span>04/28/2025</td></tr><tr><td><span class="bold">Phone: </span>956-789-3722</td></tr><tr><td colspan="2"><span class="bold">Address: </span>102 N CANAL AVE, MISSION, TX-78572-5023</td></tr><tr><td colspan="2"><span class="bold">Pcp: </span>Hobert Smith</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   Follow up: HTN, mixed hyperlipidemia, and DM2</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">Routine F/U</span>: <br/>       This is an 83 y/o Female patient presents to clinic for management of chronic conditions.<br/>Pt accompanied by daughter whom states patient is not eating properly and refuses to shower.<br/>Patient denies illness or hospitalization since last office visit and reports taking medication as prescribed and tolerating it well without side effects.<br/>  Patient denies chest pain, tachypnea, diaphoresis, shortness of breath, dizziness, headache, or palpitations at the present. <br/>  Pt otherwise has no other complaints currently<br/>Pt pending to bring  stool sample for FOBT ordered at her LOV.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">General / Constitutional</span>: <br/>      - denies fever or chills.   <br/>   <span class="Underline">Allergy / Immunology</span>: <br/>      - denies lymphadenopathy.   <br/>   <span class="Underline">ENT</span>: <br/>      - denies change in vision, denies redness, denies drainage, denies nasal congestion or discharge, denies sore throat.   <br/>   <span class="Underline">Endocrine</span>: <br/>      - denies fatigue, denies polyuria, denies polydypsia.   <br/>   <span class="Underline">Cardiovascular</span>: <br/>      - denies chest pain, palpitations, edema or diaphoresis, denies orthopnea or PND.   <br/>   <span class="Underline">Gastrointestinal</span>: <br/>      - denies nausea, vomiting, abdominal pain or distention, or change in bowel habits, denies black stools or blood in stools.   <br/>   <span class="Underline">Hematology</span>: <br/>      - denies bruising or unusal bleeding.   <br/>   <span class="Underline">Genitourinary</span>: <br/>      - denies dysuria, increased frequency, hematuria or discharge, denies incontinence.   <br/>   <span class="Underline">Musculoskeletal</span>: <br/>      - denies unusual aches or pains.   <br/>   <span class="Underline">Peripheral Vascular</span>: <br/>      - denies claudication, rest pain or gangrene.   <br/>   <span class="Underline">Skin</span>: <br/>      - denies rash or new skin lesions.   <br/>   <span class="Underline">Neurologic</span>: <br/>      - denies seizures or syncope, tremors or weakness, denies  headaches or confusion.   <br/>   <span class="Underline">Psychiatric</span>: <br/>      - normal mood, denies hallucinations or suicidal ideations.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> <br/>Problems: Allergic rhinitis due to pollen<br/>Anemia<br/>Anxiety<br/>Atherosclerosis of aorta<br/>Bacteriuria<br/>Body mass index 30+ - obesity<br/>Bradycardia<br/>Chronic kidney disease due to hypertension<br/>Chronic kidney disease due to type 2 diabetes mellitus<br/>Chronic kidney disease stage 4<br/>Chronic recurrent major depressive disorder<br/>Congestive heart failure<br/>Decrease in appetite<br/>Essential hypertension<br/>History of total knee arthroplasty<br/>Hypertensive heart and renal disease with (congestive) heart failure<br/>Impacted cerumen in left ear<br/>Insomnia<br/>Long-term drug therapy<br/>Malaise and fatigue<br/>Mixed hyperlipidemia<br/>Moderate recurrent major depression<br/>Morbid obesity<br/>Multiple complications due to type 2 diabetes mellitus<br/>Peripheral vascular disease<br/>Postmenopausal state<br/>Rheumatoid arthritis<br/>Screening for malignant neoplasm of colon<br/>Swelling of lower leg<br/>Vertigo of central origin<br/>Vitamin D deficiency<br/>BMI 35.0-35.9,adult<br/>Medical History Verified</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Gyn History:</span> <br/>   Menstrual history:<br/>         LMP: <span class="italics"> total hysterectomy</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> <br/>Breast biopsy 01/01/1988 <br/>Total hysterectomy 01/01/1996 <br/>Cholecystectomy 01/01/2010 <br/>Total knee arthroplasty (27447) 01/01/2011 <br/>Surgical History verified. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> <br/>sths dx bradycardia, hypotension 09/22/2024-09/24/2024 09/2024 <br/>Hospitalization Verified. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> 2 son(s) , 2 daughter(s) . . Family History Verified.. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   <span class="Underline">Tobacco Use:</span> <br/>       Tobacco Use/Smoking <br/>         Tobacco use: <span class="italics">nonsmoker</span><br/>   <span class="Underline">Drugs/Alcohol:</span> <br/>       Alcohol Screen (Audit-C) <br/>         Did you have a drink containing alcohol in the past year? <span class="italics">No</span><br/>         Points <span class="italics">0</span><br/>         Interpretation <span class="italics">Negative</span><br/>      Caffeine <br/>         Intake: <span class="italics">none</span><br/>      Do you drink alcohol?: No. <br/>   Social History Verified.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingAlpha Lipoic Acid 300 mg Capsule 1 capsule Orally Once a day Aspirin 81 MG Tablet Chewable 1 tablet Orally Once a day Atorvastatin Calcium 40 MG Tablet 1 tablet Orally Once a day Clopidogrel Bisulfate 75 MG Tablet 1 tablet Orally Once a day Donepezil HCl 5 MG Tablet 1 tablet at bedtime Orally Once a day Farxiga 10 MG Tablet 1 tablet Orally Once a day Isosorbide Mononitrate ER 30 MG Tablet Extended Release 24 Hour 1 tablet in the morning Orally Once a day Lisinopril 10 MG Tablet 1 tablet Orally Once a day traZODone HCl 50 MG Tablet 1 tablet at bedtime Orally Once a day Taking Alpha Lipoic Acid 300 mg Capsule 1 capsule Orally Once a day Taking Aspirin 81 MG Tablet Chewable 1 tablet Orally Once a day Taking Atorvastatin Calcium 40 MG Tablet 1 tablet Orally Once a day Taking Clopidogrel Bisulfate 75 MG Tablet 1 tablet Orally Once a day Taking Donepezil HCl 5 MG Tablet 1 tablet at bedtime Orally Once a day Taking Farxiga 10 MG Tablet 1 tablet Orally Once a day Taking Isosorbide Mononitrate ER 30 MG Tablet Extended Release 24 Hour 1 tablet in the morning Orally Once a day Taking Lisinopril 10 MG Tablet 1 tablet Orally Once a day Taking traZODone HCl 50 MG Tablet 1 tablet at bedtime Orally Once a day Not-TakingVitamin D3 25 MCG (1000 UT) Tablet 1 tablet Orally Once a day Medication List reviewed and reconciled with the patientNot-Taking Vitamin D3 25 MCG (1000 UT) Tablet 1 tablet Orally Once a day Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> Cortisone: Allergy - Onset Date 02/15/2023yesAllergies Verified.</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Ht: 60.00 in, Wt: 170 lbs, Wt-kg: 77.11 kg, BMI: 33.2 Index, BP: 130/85 mm Hg, HR: 78 /min, Temp: 98.3 F, Pain scale: 0 1-10, Body Surface Area: 1.8, Ht-cm: 152.4 cm.</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><span class="bold">   Past Orders:</span></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:TSH (899) (Order Date - 04/15/2025) (Collection Date &amp; Time - 04/15/2025 01:19 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        TSH</td><td align="left">1.75</td><td align="left"/><td align="left">0.40-4.50 - mIU/L</td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:HEMOGLOBIN A1c (496) (Order Date - 04/15/2025) (Collection Date &amp; Time - 04/15/2025 01:19 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        HEMOGLOBIN A1c</td><td align="left">6.2</td><td align="left">H</td><td align="left">&lt;5.7 - %</td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:URINALYSIS, COMPLETE (5463) (Order Date - 04/15/2025) (Collection Date &amp; Time - 04/15/2025 01:19 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        COLOR</td><td align="left">DARK YELLOW</td><td align="left"/><td align="left">YELLOW - </td></tr><tr><td align="left">        APPEARANCE</td><td align="left">TURBID</td><td align="left">A</td><td align="left">CLEAR - </td></tr><tr><td align="left">        BILIRUBIN</td><td align="left">NEGATIVE</td><td align="left"/><td align="left">NEGATIVE - </td></tr><tr><td align="left">        KETONES</td><td align="left">TRACE</td><td align="left">A</td><td align="left">NEGATIVE - </td></tr><tr><td align="left">        SPECIFIC GRAVITY</td><td align="left">1.033</td><td align="left"/><td align="left">1.001-1.035 - </td></tr><tr><td align="left">        OCCULT BLOOD</td><td align="left">TRACE</td><td align="left">A</td><td align="left">NEGATIVE - </td></tr><tr><td align="left">        PH</td><td align="left">5.5</td><td align="left"/><td align="left">5.0-8.0 - </td></tr><tr><td align="left">        PROTEIN</td><td align="left">1+</td><td align="left">A</td><td align="left">NEGATIVE - </td></tr><tr><td align="left">        NITRITE</td><td align="left">NEGATIVE</td><td align="left"/><td align="left">NEGATIVE - </td></tr><tr><td align="left">        LEUKOCYTE ESTERASE</td><td align="left">2+</td><td align="left">A</td><td align="left">NEGATIVE - </td></tr><tr><td align="left">        WBC</td><td align="left">20-40</td><td align="left">A</td><td align="left">&lt; OR = 5 - /HPF</td></tr><tr><td align="left">        RBC</td><td align="left">0-2</td><td align="left"/><td align="left">&lt; OR = 2 - /HPF</td></tr><tr><td align="left">        SQUAMOUS EPITHELIAL CELLS</td><td align="left">PACKED</td><td align="left">A</td><td align="left">&lt; OR = 5 - /HPF</td></tr><tr><td align="left">        YEAST</td><td align="left">FEW</td><td align="left">A</td><td align="left">NONE SEEN - /HPF</td></tr><tr><td align="left">        BACTERIA</td><td align="left">MANY</td><td align="left">A</td><td align="left">NONE SEEN - /HPF</td></tr><tr><td align="left">        HYALINE CAST</td><td align="left">10-20</td><td align="left">A</td><td align="left">NONE SEEN - /LPF</td></tr><tr><td align="left">        GLUCOSE</td><td align="left">3+</td><td align="left">A</td><td align="left">NEGATIVE - </td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:CBC (INCLUDES DIFF/PLT) (6399) (Order Date - 04/15/2025) (Collection Date &amp; Time - 04/15/2025 01:19 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        WHITE BLOOD CELL COUNT</td><td align="left">6.3</td><td align="left"/><td align="left">3.8-10.8 - Thousand/uL</td></tr><tr><td align="left">        RED BLOOD CELL COUNT</td><td align="left">3.70</td><td align="left">L</td><td align="left">3.80-5.10 - Million/uL</td></tr><tr><td align="left">        HEMOGLOBIN</td><td align="left">12.1</td><td align="left"/><td align="left">11.7-15.5 - g/dL</td></tr><tr><td align="left">        HEMATOCRIT</td><td align="left">35.5</td><td align="left"/><td align="left">35.0-45.0 - %</td></tr><tr><td align="left">        MCV</td><td align="left">95.9</td><td align="left"/><td align="left">80.0-100.0 - fL</td></tr><tr><td align="left">        MCH</td><td align="left">32.7</td><td align="left"/><td align="left">27.0-33.0 - pg</td></tr><tr><td align="left">        MCHC</td><td align="left">34.1</td><td align="left"/><td align="left">32.0-36.0 - g/dL</td></tr><tr><td align="left">        RDW</td><td align="left">16.2</td><td align="left">H</td><td align="left">11.0-15.0 - %</td></tr><tr><td align="left">        PLATELET COUNT</td><td align="left">150</td><td align="left"/><td align="left">140-400 - Thousand/uL</td></tr><tr><td align="left">        NEUTROPHILS</td><td align="left">64.4</td><td align="left"/><td align="left"> - %</td></tr><tr><td align="left">        ABSOLUTE NEUTROPHILS</td><td align="left">4057</td><td align="left"/><td align="left">1500-7800 - cells/uL</td></tr><tr><td align="left">        LYMPHOCYTES</td><td align="left">29.3</td><td align="left"/><td align="left"> - %</td></tr><tr><td align="left">        ABSOLUTE LYMPHOCYTES</td><td align="left">1846</td><td align="left"/><td align="left">850-3900 - cells/uL</td></tr><tr><td align="left">        MONOCYTES</td><td align="left">4.6</td><td align="left"/><td align="left"> - %</td></tr><tr><td align="left">        ABSOLUTE MONOCYTES</td><td align="left">290</td><td align="left"/><td align="left">200-950 - cells/uL</td></tr><tr><td align="left">        EOSINOPHILS</td><td align="left">1.4</td><td align="left"/><td align="left"> - %</td></tr><tr><td align="left">        ABSOLUTE EOSINOPHILS</td><td align="left">88</td><td align="left"/><td align="left">15-500 - cells/uL</td></tr><tr><td align="left">        BASOPHILS</td><td align="left">0.3</td><td align="left"/><td align="left"> - %</td></tr><tr><td align="left">        ABSOLUTE BASOPHILS</td><td align="left">19</td><td align="left"/><td align="left">0-200 - cells/uL</td></tr><tr><td align="left">        MPV</td><td align="left">9.5</td><td align="left"/><td align="left">7.5-12.5 - fL</td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:COMPREHENSIVE METABOLIC PANEL (10231) (Order Date - 04/15/2025) (Collection Date &amp; Time - 04/15/2025 01:19 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        GLUCOSE</td><td align="left">117</td><td align="left">H</td><td align="left">65-99 - mg/dL</td></tr><tr><td align="left">        UREA NITROGEN (BUN)</td><td align="left">15</td><td align="left"/><td align="left">7-25 - mg/dL</td></tr><tr><td align="left">        CREATININE</td><td align="left">1.17</td><td align="left">H</td><td align="left">0.60-0.95 - mg/dL</td></tr><tr><td align="left">        BUN/CREATININE RATIO</td><td align="left">13</td><td align="left"/><td align="left">6-22 - (calc)</td></tr><tr><td align="left">        SODIUM</td><td align="left">142</td><td align="left"/><td align="left">135-146 - mmol/L</td></tr><tr><td align="left">        POTASSIUM</td><td align="left">3.2</td><td align="left">L</td><td align="left">3.5-5.3 - mmol/L</td></tr><tr><td align="left">        CHLORIDE</td><td align="left">108</td><td align="left"/><td align="left">98-110 - mmol/L</td></tr><tr><td align="left">        CARBON DIOXIDE</td><td align="left">23</td><td align="left"/><td align="left">20-32 - mmol/L</td></tr><tr><td align="left">        CALCIUM</td><td align="left">8.6</td><td align="left"/><td align="left">8.6-10.4 - mg/dL</td></tr><tr><td align="left">        PROTEIN, TOTAL</td><td align="left">6.6</td><td align="left"/><td align="left">6.1-8.1 - g/dL</td></tr><tr><td align="left">        ALBUMIN</td><td align="left">3.7</td><td align="left"/><td align="left">3.6-5.1 - g/dL</td></tr><tr><td align="left">        GLOBULIN</td><td align="left">2.9</td><td align="left"/><td align="left">1.9-3.7 - g/dL (calc)</td></tr><tr><td align="left">        ALBUMIN/GLOBULIN RATIO</td><td align="left">1.3</td><td align="left"/><td align="left">1.0-2.5 - (calc)</td></tr><tr><td align="left">        BILIRUBIN, TOTAL</td><td align="left">0.8</td><td align="left"/><td align="left">0.2-1.2 - mg/dL</td></tr><tr><td align="left">        ALKALINE PHOSPHATASE</td><td align="left">85</td><td align="left"/><td align="left">37-153 - U/L</td></tr><tr><td align="left">        AST</td><td align="left">15</td><td align="left"/><td align="left">10-35 - U/L</td></tr><tr><td align="left">        ALT</td><td align="left">7</td><td align="left"/><td align="left">6-29 - U/L</td></tr><tr><td align="left">        EGFR</td><td align="left">46</td><td align="left">L</td><td align="left">&gt; OR = 60 - mL/min/1.73m2</td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:ALBUMIN, RANDOM URINE W/CREATININE (6517) (Order Date - 04/15/2025) (Collection Date &amp; Time - 04/15/2025 01:19 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        CREATININE, RANDOM URINE</td><td align="left">185</td><td align="left"/><td align="left">20-275 - mg/dL</td></tr><tr><td align="left">        ALBUMIN, URINE</td><td align="left">1.4</td><td align="left"/><td align="left">See Note: - mg/dL</td></tr><tr><td align="left">        ALBUMIN/CREATININE RATIO, RANDOM URINE</td><td align="left">8</td><td align="left"/><td align="left">&lt;30 - mg/g creat</td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:LIPID PANEL, STANDARD (7600) (Order Date - 04/15/2025) (Collection Date &amp; Time - 04/15/2025 01:19 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        TRIGLYCERIDES</td><td align="left">102</td><td align="left"/><td align="left">&lt;150 - mg/dL</td></tr><tr><td align="left">        CHOLESTEROL, TOTAL</td><td align="left">139</td><td align="left"/><td align="left">&lt;200 - mg/dL</td></tr><tr><td align="left">        HDL CHOLESTEROL</td><td align="left">40</td><td align="left">L</td><td align="left">&gt; OR = 50 - mg/dL</td></tr><tr><td align="left">        LDL-CHOLESTEROL</td><td align="left">80</td><td align="left"/><td align="left"> - mg/dL (calc)</td></tr><tr><td align="left">        CHOL/HDLC RATIO</td><td align="left">3.5</td><td align="left"/><td align="left">&lt;5.0 - (calc)</td></tr><tr><td align="left">        NON HDL CHOLESTEROL</td><td align="left">99</td><td align="left"/><td align="left">&lt;130 - mg/dL (calc)</td></tr><tr><td colspan="4"><br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      General appearance: well-appearing, no acute distress , morbid obese , chaperone present in room, (daughter) . <br/>      Neck / thyroid: no JVD, no lymphadenopathy, no thyromegaly, no carotid bruit. <br/>      Heart: regular rhythm, S1S2 normal, no S3 S4, no murmur, gallop or rub. <br/>      Chest: symmetric without any chest wall tenderness. <br/>      Lungs: clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes. <br/>      Abdomen: soft, non tender, not distended, BS +, no organomegaly. <br/>      Neurologic: conscious, AAO x 3, no new focal deficits. <br/>      Extremities no edema.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin - E11.69 (Primary)   2. Mixed hyperlipidemia - E78.2   3. Type 2 diabetes mellitus with diabetic chronic kidney disease - E11.22   4. Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene, without long-term current use of insulin - E11.51   5. Hyp hrt &amp; chr kdny dis w hrt fail and stg 1-4/unsp chr kdny - I13.0   6. Chronic kidney disease, stage 3a - N18.31   7. Immunodeficiency due to conditions classified elsewhere - D84.81   8. Major depressive disorder, recurrent, mild - F33.0   9. Insomnia, unspecified - G47.00   10. NSTEMI (non-ST elevated myocardial infarction) - I21.4   11. Severe dementia without behavioral disturbance, psychotic disturbance, mood disturbance, or anxiety, unspecified dementia type - F03.C0   12. Sinus bradycardia - R00.1   13. Atherosclerosis of native coronary artery of native heart without angina pectoris - I25.10   14. BMI 35.0-35.9,adult - Z68.35   15. Vaginal candidiasis - B37.31   16. Asymptomatic bacteriuria - R82.71   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin</span> <br/>Continue Farxiga Tablet, 10 MG, 1 tablet, Orally, Once a day, 100 days, 100 Tablet, Refills 1.  <br/>Notes: This is associated with hyperlipidemia. DM well controlled.<br/>Most recent HbA1c 6.2% on 4-8-2025<br/>HbA1c goal &lt;8% without hypoglycemic events., <content>PT advised pt to continue to monitor fbs at home. advised pt to be compliant on all meds-pt VGA PT educated on dietary restrictions including avoiding fat and carbohydrate rich foods. Pt advised to eat a balanced diet, at regular times and not skip meals. PT was also educated on portion control and the importance of avoidance of simple sugars and sodas. lifestyle changes are also necessary to prevent complications and control condition, she was encouraged to increase activity as tolerated and lose weight. <br/> Follow up with PCP as scheduled</content>  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Mixed hyperlipidemia</span> <br/>Continue Atorvastatin Calcium Tablet, 40 MG, 1 tablet, Orally, Once a day, 100 days, 100 Tablet, Refills 1.  <br/>Notes: Stable. This is associated with T2 DM. <content>P<content>atient advised to continue with medications as prescribed.<br/> </content>Continue with a low glycemic diet. Discussed the importance of taking a statin. Goal maintain LDL less than 70, HDL great than 40, triglycerides less than 150 and A1c goal &lt;8%., Recommend a "heart-healthy diet" rich in vegetables, fruits, fiber-rich whole grains, lean meats, and poultry; fish at least twice a week; fat-free or 1% dairy products; low in saturated and trans fats, cholesterol, sodium, and added sugars., The patient also was advised to exercise regularly and lose about 10 pounds., Follow up with PCP. </content>  </td></tr><tr><td/></tr><tr><td><span class="bold">3. Type 2 diabetes mellitus with diabetic chronic kidney disease</span> <br/>Notes: Stable., Secondary to diabetic nephropathy<br/>Patient needs to take medications as directed by MD. Stressed control of blood sugars and blood pressure. Monitor renal function q 3-6 months. Avoid nephrotoxins, NSAIDs and need to hydrate well. Nephrology consults prn., Patient is to control blood sugars and blood pressure  </td></tr><tr><td/></tr><tr><td><span class="bold">4. Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene, without long-term current use of insulin</span> <br/>Continue Alpha Lipoic Acid Capsule, 300 mg, 1 capsule, Orally, Once a day, 90 days, 90 Capsule, Refills 1, Notes to Pharmacist: *Pick strength-form from Medispan for eRX*.  <br/>Notes: Patient will continue strict glucose, blood pressure, and lipid management. Increase daily physical activity as tolerated. Continue statin. Monitor feet/legs for lesions and loss of circulation. Avoid walking barefoot. Report any abnormal findings to PCP.  </td></tr><tr><td/></tr><tr><td><span class="bold">5. Hyp hrt &amp; chr kdny dis w hrt fail and stg 1-4/unsp chr kdny</span> <br/>Refill Lisinopril Tablet, 10 MG, 1 tablet, Orally, Once a day, 100 days, 100 Tablet, Refills 1.  <br/>Notes: BP well controlled.,  BP: 130/85 mm Hg<br/>This is ckd secondary to hypertensive nephropathy<br/>Pt instructed to needs to avoid NSDAs and nephrotoxic drugs., to continues with<br/>ACE inhibitor and farxiga to reduce the risk of sustained gfr decline at risk<br/>of progression., rigorous blood pressure control should be done as early as<br/>possible after identifying the presence of progressive ckd. Blood pressure goal<br/>&lt; 130/80 mmhg., protective therapy has the greatest impact if it is<br/>initiated before the plasma creatinine concentration exceeds 1.2 mg/dl or when<br/>the egfr is &lt;60. - will keep monitoring gfr, ck<br/><br/>diet: decrease the daily intake of sodium, phosphorus,<br/>calcium and potassium - avoid dehydration, contrast material., Pt will report new or worsening symptoms. ,<br/>Nephrologist referral as needed.  </td></tr><tr><td/></tr><tr><td><span class="bold">6. Chronic kidney disease, stage 3a</span> <br/>Notes: CKD, Stable.<br/>Secondary to diabetic nephropathy and hypertensive nephropathy<br/>Pt instructed to needs to avoid NSDAs and nephrotoxic drugs., to continues with<br/>ACE inhibitor and farxiga to reduce the risk of sustained gfr decline at risk<br/>of progression<br/>Reinforced importance of control of risk factors, htn DM, HLD., Continue with medication<br/>as indicated for all chronic conditions. Patient advised on the importance of<br/>dietary modifications including a DASH, 1800 cal-ADA and low fat/cholesterol<br/>diet. Increase water intake. Advised to stay hydrated.<br/>Follow up with PCP.  <br/>Clinical Notes: <span class="content_span">Continue surveillance with</span> kidney specialist Dr Franklin Ponce Herrera. LOV 3-31-2025  </td></tr><tr><td/></tr><tr><td><span class="bold">7. Immunodeficiency due to conditions classified elsewhere</span> <br/>Notes: <span class="content_span">Patient is immunosuppressed due to DM. Discussed with patient that chronic elevated blood sugars increased risk for infections due to immunosuppression. Will revise medication list and observe for potential changes. Stressed the importance of diet and exercise. Patient understands risk. Patient advised to seek medical care if she develops any clinical signs and symptoms suggestive of infection.</span>  </td></tr><tr><td/></tr><tr><td><span class="bold">8. Major depressive disorder, recurrent, mild</span> <br/>Notes: <span class="content_span">Currently patient is asymptomatic.; symptoms are stable., Plan to continue current management and to re-evaluate patient at follow up., Patient denies suicidal or homicidal ideation.  pt to notify provider of any behavioral changes or suicidal thoughts. Patient was advised to call or come in if symptoms develop., pt to participate in daily activities and socializing when he starts to feel down. RTC as scheduled. PHQ yearly, and prn., Patient verbalized understanding. </span>    </td></tr><tr><td/></tr><tr><td><span class="bold">9. Insomnia, unspecified</span> <br/>Refill traZODone HCl Tablet, 50 MG, 1 tablet at bedtime, Orally, Once a day, 90 days, 90 Tablet, Refills 1.  <br/>Notes: Review proper sleeping hygiene. Avoid exercising and stimulating activities in the evening. Encourage reading and soothing noises. Thoroughly discussed sleep hygiene and non-stimulating activities before bed, reduce caffeine. He was recommended to avoid napping during day. Start exercise at least 30 minutes daily. May use chamomile tea before bed to help induce sleep. Will continue to follow up with patient.  </td></tr><tr><td/></tr><tr><td><span class="bold">10. NSTEMI (non-ST elevated myocardial infarction)</span> <br/>Notes: As per hospital discharge summary. Advised to continue with current medications. Refill provided. I will refer patient Cardiologist for evaluation and treatment.   </td></tr><tr><td/></tr><tr><td><span class="bold">11. Severe dementia without behavioral disturbance, psychotic disturbance, mood disturbance, or anxiety, unspecified dementia type</span> <br/>Refill Donepezil HCl Tablet, 5 MG, 1 tablet at bedtime, Orally, Once a day, 100 days, 100, Refills 1.  <br/>Notes: stable. monitor closely.<br/>med refilled <br/>Encouraged memory exercises daily. Maintain routine schedule whenever possible with ADL's and meal time.  </td></tr><tr><td/></tr><tr><td><span class="bold">12. Sinus bradycardia</span> <br/>Notes: As per hospital discharge summary<br/>Refer to Cardiologist for evaluation and treatment.   </td></tr><tr><td/></tr><tr><td><span class="bold">13. Atherosclerosis of native coronary artery of native heart without angina pectoris</span> <br/>Continue Clopidogrel Bisulfate Tablet, 75 MG, 1 tablet, Orally, Once a day, 90 days, 90, Refills 1; Continue Aspirin Tablet Chewable, 81 MG, 1 tablet, Orally, Once a day, 90 days, 90, Refills 1.  <br/>Notes: Pt has stable BP with no cp or sob with good functional status and adequate BP control.<br/>Recommend exercise program as tolerated and high fiber, low sodium, low saturated fat, low refined sugar diet. Continue with current medications as prescribed. Follow up with PCP and cardiologist as scheduled and as needed. If chest pain should occur, call, or go to the hospital Emergency Department via EMS 911. Targets for blood pressure, lipids, glucose reviewed.<br/>  </td></tr><tr><td/></tr><tr><td><span class="bold">14. BMI 35.0-35.9,adult</span> <br/>Notes: Encouraged and stressed importance of diet and physical activity to improve BMI and overall health. Discussed obtaining goal BMI through diet and exercise program.  </td></tr><tr><td/></tr><tr><td><span class="bold">15. Vaginal candidiasis</span> <br/>Start Fluconazole Tablet, 150 MG, Take 1 tablet, Orally, first day then take the other tablet 72 hours apart, 2 days, 2, Refills 0.  <br/>Notes: Trial fluconazol x 2 doses<br/>Pt denies Hx of DM, immunodeficiency, chronic steroid use, excessive doucing, or recent Abx use. Pt advised to keep vagina dry, use 100% cotton underwear, avoid tight-fitting clothing, and avoid use of feminine deodorants/bubble baths.  </td></tr><tr><td/></tr><tr><td><span class="bold">16. Asymptomatic bacteriuria</span> <br/>     <span class="Underline">LAB: 1505 URINALYSIS WITH MICROSCOPIC (Ordered for 04/28/2025)</span><br/>Notes: She has not s/s UTI currently<br/>Suspected contamination<br/>Will repeact UA  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> G8417 BMI &gt;=30 CALCUATE W/FOLLOWUP3008F BODY MASS INDEX DOCD1159F MED LIST DOCD IN RCRD1160F RVW MEDS BY RX/DR IN RCRD</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 3 Months (Reason: Follow-up of chronic conditions)</td></tr></tbody></table></li></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99214 Office Visit, Est Pt., Level 4.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> <br/>G8417 BMI &gt;=30 CALCUATE W/FOLLOWUP. <br/>3008F BODY MASS INDEX DOCD. <br/>1159F MED LIST DOCD IN RCRD. <br/>1160F RVW MEDS BY RX/DR IN RCRD. </td></tr></tbody></table></li></ul><br/><tr><td valign="top"><span class="bold">Care Plan Details</span><ul><li><table cellpadding="1" cellspacing="0" border="1"><tbody/></table></li></ul></td></tr><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by Orlando Valdes Rodriguez , NP, 1027787  on 04/30/2025 at 06:14 AM CDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> Orlando Valdes Rodriguez, NP</td><td align="right"><span class="bold">Date: </span>04/28/2025</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: 05/14/2025 04:51 PM CDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><br/><br/></body></html>